Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Clofazimine by MannKind for Mycobacterium Infections: Likelihood of Approval
Clofazimine is under clinical development by MannKind and currently in Phase III for Mycobacterium Infections. According to GlobalData, Phase III...